# Differential Plasma Carotenoid Profiles in Hypertensive Disorders of Pregnancy

**Authors:** Colman I. Freel, Jonah Scheffler, Rebecca A. Drakowski, Elizabeth Lyden, Matthew VanOrmer, Melissa K. Thoene, Paras Kumar Mishra, Corrine K. Hanson, Ann L. Anderson-Berry

PMC · DOI: 10.3390/nu17193104 · 2025-09-29

## TL;DR

This study found that women with preeclampsia have lower levels of certain carotenoids in their blood compared to other types of pregnancy-related hypertension.

## Contribution

The study identifies distinct plasma carotenoid profiles in preeclampsia compared to other hypertensive disorders of pregnancy.

## Key findings

- Plasma β-carotene levels were significantly lower in preeclampsia compared to normotensive, chronic, and gestational hypertension groups.
- Lutein + zeaxanthin and β-cryptoxanthin were also reduced in preeclampsia compared to normotensive controls.
- α-carotene levels were lower in preeclampsia compared to both chronic and gestational hypertension.

## Abstract

Background: Hypertensive disorders of pregnancy (HDP) affect one in six pregnancies globally. The etiology of HDP remains unclear but is known to involve oxidative stress. While the body produces endogenous antioxidants, antioxidative nutrients, like carotenoids, remain critical in modulating oxidative stress. The statuses of several carotenoids have been linked to hypertension in both pregnant and non-pregnant populations. However, their associations with the spectrum of HDP, including gestational hypertension (GH), chronic hypertension (CH), and preeclampsia (PE), remains unclear. Our objective was to quantify and compare carotenoid intake and plasma levels among HDP. Methods: We conducted a prospective cohort study of patients presenting for delivery at a Midwestern academic medical center between 2015 and 2023. Women ≥ 19 years old delivering at least one infant were eligible for inclusion. Mothers with diseases affecting nutrient metabolism or birthing newborn wards of the state were excluded. Subjects were recruited at delivery for Harvard Food Frequency Questionnaire and plasma sample collection. Plasma carotenoids were analyzed by HPLC-MS. Results: A total of 488 patients, including 270 normotensive (NT), 61 CH, 102 GH, and 55 PE, were recruited. Plasma carotenoid analyses were available for 225 subjects. Plasma total, cis-, and trans-β-carotene were significantly lower in PE (73 mcg/L) compared to NT (170 mcg/L), CH (194 mcg/L), and GH (190 mcg/L) groups. Lutein + zeaxanthin and β-cryptoxanthin were also reduced in PE (142 mcg/L and 81 mcg/L) compared to NT (209 mcg/L and 123 mcg/L) but only β-cryptoxanthin was lower in PE compared to GH (126 mcg/L). Levels of α-carotene were lower in PE (18 mcg/L) compared to both CH (43 mcg/L) and GH (48 mcg/L). Conclusions: These results demonstrate that plasma carotenoid levels differ among HDP and may suggest that oxidative stress in PE depletes circulating carotenoids, differentiating it from other HDP.

## Linked entities

- **Chemicals:** β-carotene (PubChem CID 573), lutein (PubChem CID 181579), zeaxanthin (PubChem CID 5280899), β-cryptoxanthin (PubChem CID 5281235), α-carotene (PubChem CID 4369188)
- **Diseases:** gestational hypertension (MONDO:0024664), preeclampsia (MONDO:0005081)

## Full-text entities

- **Diseases:** PE (MESH:D011225), GH (MESH:D046110), CH (MESH:D006973)
- **Chemicals:** Lutein (MESH:D014975), cis-, and trans-beta-carotene (-), zeaxanthin (MESH:D065146), alpha-carotene (MESH:C041635), beta-cryptoxanthin (MESH:D000072743), Carotenoid (MESH:D002338)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12525936/full.md

---
Source: https://tomesphere.com/paper/PMC12525936